The Speaking Out video series ensures that we are giving patients, caregivers, and advocates as much helpful information as possible for their cancer journey. In this series, we work with leading cancer advocacy groups to offer advice and assistance to individuals across various cancer types, as well as their caregivers, advocates, and health care professionals.
As part of its Speaking Out video series, CURE spoke with Emily Whitehead Foundation co-founder and president Tom Whitehead, Bruce L. Levine of the
University of Pennsylvania Perelman School of Medicine and Hannah-Lise Schofield of the Children’s Hospital of Philadelphia about advancements in treatments for young patients with cancer and addressing the needs of patients and their families beyond treatment.
Read More
Trials, Treatments, Addressing Toxicities: Help Available for Patients with Leukemia, Lymphoma
August 23rd 2023As part of its Speaking Out video series, CURE spoke with Nikki Yuill and Dr. Lee Greenberger of the Leukemia & Lymphoma Society, about challenges faced by patients, resources that are available to them and recent advancements in treatment.
Read More
Boiling Down Self-Advocacy For Testing, Second Opinions and More During a Lung Cancer Diagnosis
February 24th 2023As a part of its Speaking Out Video series, CURE® spoke with Terri Conneran, founder of KRAS Kickers, about the importance of patients advocating for themselves for testing, second opinions, networking and more during a lung cancer diagnosis.
Read More
Evaluating Surgical Options With Decision-Making in Early-Stage Lung Cancer
November 23rd 2022As part of its “Speaking Out” video series, Dr. Peter Baik, on behalf of Cancer Treatment Centers of America, discussed surgical options and the decision-making process in early-stage lung cancer, as well as disparities still in the screening of the disease.
Read More
Highlighting the Importance of Clinical Trials, Patient-Physician Communication in Bladder Cancer
September 29th 2022As part of its “Speaking Out” video series, CURE® spoke with Dr. Tracy L. Rose, on behalf of the Bladder Cancer Advocacy Network, about advances in treatment and clinicals trials, while offering options for support for both patients and caregivers alike.
Read More
Women’s Cancer: Addressing Barriers and Maintaining Health During Treatment Into Survivorship
May 27th 2022As part of its Speaking Out video series, CURE spoke with Dr. Navya Nair, on behalf of the Foundation for Women’s Cancer, about access to care, maintaining health, genetics and survivorship in women’s cancer.
Read More
Collaborating to Raise Awareness Around Multiple Myeloma
March 3rd 2022As part of its Speaking Out video series, CURE spoke with Throwing Bones founder, Kenny Caps about patient-physician communication, treating myeloma as a chronic condition and how to raise more awareness around the disease.
Read More
Long-Term Care for MPNs: How Patients and Caregivers Can Find Care Teams and Advocate for Themselves
February 24th 2022As part of its Speaking Out video series, on behalf of the Canadian MPN Research Foundation, CURE spoke with two experts on the long-term care of myeloproliferative neoplasms.
Read More
Head and Neck Cancer: Self Exams, Vaccines, Treatment and More
May 12th 2021In this edition of the Speaking Out video series, on behalf of the Head and Neck Cancer Alliance,CURE spoke with Dr. Michael Moore, from Indiana University School of Medicine about the basics of head and neck cancer.
Read More
Living With Pancreatic Cancer: a Patient and Provider Perspective
January 24th 2021On behalf of the National Pancreas Foundation, CURE spoke with Dr. Michael Goggin, from Johns Hopkins Medicine, and Tom Birsic, an executive board member since the organization’s inception, about living with pancreatic cancer.
Read More
Learning the Basics of a Rare Disease: Cutaneous T-Cell Lymphoma
January 19th 2021On behalf of the Cutaneous Lymphoma Foundation, CURE spoke with Drs. Steven M. Horwitz and Lauren Pinter-Brown about the basics of cutaneous T-cell lymphoma, as well as current treatment options and those being evaluated for the rare disease.
Read More